Table:
begin	end	state
1	5	non-cytoplasmic
6	34	transmembrane
35	54	cytoplasmic
55	74	transmembrane
75	93	non-cytoplasmic
94	113	transmembrane
114	133	cytoplasmic
134	160	transmembrane
161	169	non-cytoplasmic
170	191	transmembrane
192	210	cytoplasmic
211	232	transmembrane
233	235	non-cytoplasmic
236	236	transmembrane
237	239	non-cytoplasmic
240	258	transmembrane
259	277	cytoplasmic
278	295	transmembrane
296	314	non-cytoplasmic
315	345	transmembrane
346	356	cytoplasmic
357	381	transmembrane
382	398	non-cytoplasmic
399	423	transmembrane
424	424	cytoplasmic

Input:
>WP_094508088.1 NCBI__GCF_002252445.1:WP_094508088.1
MSLTTIVLIMLALIALNMRLYVAILIAVFTYFIFFNQMPIAIAVQRFISPAQNTSLLAIP
FFIMLGTVMSHTGIAERLIKVADILVGRMRGGMALTNIMVSTLMGGVSASNLADSAMLTR
MMVPEMVKRGYDKAFSCAVTAAGSLITPIIPPGIALIIYGLIADVSIGKMFMAGVVPGIL
GAVILMIAAYITSVKRGYKPSREKRMSGAEVASTLASAWPAVLLLFAIIGGIRMNIFTPT
EAGAVAVTLVLIIGFVIYREMRVSHVVDSLIETAKSTASVMLVIMASSALAWVFSLEQAG
QALMHLISSFTSNPYAFLLAVNVILLLLGALIEGTALMIVLVPLLMPTVKALGIDPVHFG
IVVIVNLSIGTLTPPVGTVMLMVCNIAKVRVADFTRQAFSMYLALFILLALVTYVPFIST
FLAH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server